help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 21, 2004
Endocrinology, doi:10.1210/en.2003-1322
A more recent version of this article appeared on May 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/5/2458    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TOKUDOME, T.
Right arrow Articles by KANGAWA, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOKUDOME, T.
Right arrow Articles by KANGAWA, K.

Submitted on October 2, 2003
Accepted on January 14, 2004

Ventricular Nonmyocytes Inhibit Doxorubicin-Induced Myocyte Apoptosis: Involvement of Endogenous Endothelin-1 as a Paracrine Factor

TAKESHI TOKUDOME, TAKESHI HORIO*, MEGUMU FUKUNAGA, HIROYUKI OKUMURA, JUN HINO, KENJI MORI, FUMIKI YOSHIHARA, SHIN-ICHI SUGA, YUHEI KAWANO, MASAKAZU KOHNO, and KENJI KANGAWA

Research Institute (T.T., H.O., J.H., K.M., S.S., K.K.) and Department of Medicine (T.H., F.Y., Y.K.), National Cardiovascular Center, Suita, Osaka 565-8565, Japan; and Department of Integrated Medicine (M.F.) and Second Department of Internal Medicine (M.K.), Kagawa University Faculty of Medicine, Kagawa 761-0793, Japan.

* To whom correspondence should be addressed. E-mail: thorio{at}ri.ncvc.go.jp.

A cross-talk between cardiac myocytes and nonmyocytes via humoral factors plays an important role in the development of cardiac growth. However, it remains to be elucidated whether humoral factors produced from nonmyocytes have a protective effect on acute myocardial injury. The present in vitro study investigated the antiapoptotic effect of nonmyocytes on doxorubicin (DOX)-induced myocyte apoptosis and its molecular mechanism. Myocyte-nonmyocyte coculture and treatment with nonmyocyte-conditioned media significantly attenuated DOX-induced myocyte apoptosis. Treatment with nonmyocyte-conditioned media stimulated the phosphorylation of ERK, Akt, and cAMP response element-binding protein (CREB) in myocytes. Nonmyocyte-conditioned media also increased protein levels of Bcl-2 but not Bcl-xL and decreased caspase-3 activation induced by DOX. MEK-1-specific inhibitor PD98059, phosphatidylinositol-3 kinase-Akt inhibitor LY294002, and CREB antisense oligonucleotide significantly blocked the antiapoptotic effect of nonmyocyte-conditioned media. A considerable amount of endothelin-1 (ET-1) production was detected in nonmyocytes, but not in myocytes. Exogenous ET-1 mimicked nonmyocyte-conditioned media-mediated ERK and CREB phosphorylation and Bcl-2 protein increase but not Akt phosphorylation. In addition, ET-A receptor antagonists BQ123 and BQ485 partially blocked nonmyocyte-conditioned media-mediated antiapoptotic effect, ERK and CREB phosphorylation, and Bcl-2 protein increase. Nonmyocyte-conditioned media and exogenous ET-1 unchanged protein levels of manganese superoxide dismutase and oxidative stress-related product levels augmented by DOX. The present findings demonstrate that cardiac nonmyocytes inhibit DOX-induced myocyte apoptosis, at least in part, via ET-1 secretion-mediated CREB activation independent of the decrease in oxidative stress.


Key words: endothelin • doxorubicin • myocytes • nonmyocytes • apoptosis




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. Beaumont, T. Arias, S. Ravassa, and J. Diez
Overexpression of human truncated peroxisome proliferator-activated receptor {alpha} induces apoptosis in HL-1 cardiomyocytes
Cardiovasc Res, May 17, 2008; (2008) cvn106v2.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society